1637-39-4
1637-39-4 结构式
基本信息
反-玉米素(合成)
反式玉米素
6-反式-4-羟基-3-甲基-丁-2-烯基氨基嘌呤
玉米素
6-[4-HYDROXY-3-METHYLBUT-2-ENYLAMINO]PURINE
6-[4-HYDROXY-3-METHYLBUT-2-ENYLAMINO]PURINE TRANS ISOMER
6-[(E)-4-HYDROXY-3-METHYL-2-BUTENYLAMINE]PURINE
6[(E)-4-HYDROXY-3-METHYL-2-BUTENYLAMINO] PURINE
6-(HYDROXY-3-METHYL-BUT-2-ENYLAMINO)PURINE
(E)-2-METHYL-4-(1H-PURIN-6-YLAMINO)-2-BUTEN-1-OL
N6-(4-HYDROXY-3-METHYL-2-BUTEN-1-YL)ADENINE
TRANS-2-METHYL-4-(1H-PURIN-6-YLAMINO)-BUT-2-EN-1-OL
TRANS-6-(4-HYDROXY-3-METHYLBUT-2-ENYLAMINO)PURINE
TRANS-ZEATIN
trans-Zeatin (synthetic)
ZEATIN
ZEATIN TRANS ISOMER
(e)-2-buten-1-o
(E)-Zeatin
2-Buten-1-ol,2-methyl-4-(purin-6-ylamino)-,(E)-
2-methyl-4-(1H-purin-6-ylamino)-,(E)-2-Buten-1-ol
2-methyl-4-(purin-6-ylamino)-,(E)-2-Buten-1-ol
Zeatine
物理化学性质
应用领域
制备方法
1795-76-2
87-42-3
1637-39-4
以化合物(CAS:1795-76-2)和6-氯嘌呤为原料合成(E)-4-((7H-嘌呤-6-基)氨基)-2-甲基丁-2-烯-1-醇的一般步骤如下:该合成方法参照羟基亚烷基腺嘌呤(玉米素)的制备流程,具体操作类似于实施例1的步骤(1)至(5)。主要步骤如下:将154.5 g(1 mol)的4-氯-1H-吡唑并[3,4-d]嘧啶溶解于200 mL乙醇中,加入122 g(1.2 mol)三乙胺作为碱。随后,缓慢滴加111 g(1.1 mol)的4-氨基-2-甲基-2-丁烯醇。滴加完毕后,将反应混合物加热至回流状态,持续反应5小时。反应完成后,通过旋转蒸发仪除去乙醇。向残留物中加入适量水,并用乙酸乙酯进行三次萃取。合并有机层,经无水硫酸钠干燥后,减压浓缩,得到212 g目标产物(羟基腺嘌呤)的灰色粉末,产率为96.8%。
参考文献:
[1] Patent: CN106883233, 2017, A. Location in patent: Paragraph 0047; 0048
[2] Tetrahedron, 1990, vol. 46, # 3, p. 913 - 920
知名试剂公司产品信息
trans-Zeatin (synthetic), 97%(1637-39-4)
trans-Zeatin,>98.0%(LC)(N)(1637-39-4)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/09/19 | S4884 | 反玉米蛋白 Trans-Zeatin | 1637-39-4 | 5mg | 794.74元 |
| 2025/09/19 | S4884 | 反玉米蛋白 Trans-Zeatin | 1637-39-4 | 25mg | 2433.31元 |
| 2025/05/22 | HY-19700 | 反玉米蛋白 trans-Zeatin | 1637-39-4 | 1 mg | 140元 |
常见问题列表
| Target | Value |
|
MMP-1
() | |
|
ERK
() | |
|
JNK
() | |
|
p38 MAPK
() |
trans-Zeatin is a plant cytokinin, which plays an important role in cell growth, differentiation, and division. trans-Zeatin (20, 40 or 80 μM) inhibits UV-induced MEK/ERK activation, upregulates AQP3 in a time- and dose-dependent manner, and attenuates UV induced loss of AQP3 in keratinocytes (HaCaT cells). UV-induced AQP3 downregulation is blocked by MEK/ERK inhibitors. Trans-Zeatin (80 μM) attenuates UV-induced downregulation of wound healing and water permeability in HaCaT cells.
